{
    "clinical_study": {
        "@rank": "60385", 
        "brief_summary": {
            "textblock": "This is a cross sectional study of a novel non-invasive optical flare photometer (OFAM).\n      Patients meeting the inclusion/exclusion criteria will receive a standard eye examination\n      including a slit lamp examination to collect ocular flare data. In addition to the standard\n      eye examination, subjects will receive flare measurements using the OFAM device."
        }, 
        "brief_title": "Flare Photometry in Uveitis Patients", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Actual"
        }, 
        "condition": "Uveitis", 
        "condition_browse": {
            "mesh_term": [
                "Uveitis", 
                "Chorioretinitis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age greater than 18 years\n\n          -  Ability to understand and willingness to sign a written informed consent document.\n\n          -  To be eligible for the uveitis arm of the study subjects must have active anterior\n             chamber uveitis in one or both eyes as determined by a physician\n\n          -  To be eligible for the non-inflammatory arm of the study the study subjects must have\n             no ocular inflammation in either eye as determined by a physician.\n\n        Exclusion Criteria:\n\n          -  Inability to give informed consent\n\n          -  Exclusion criteria for the uveitis arm: no active disease\n\n          -  Exclusion criteria for the non-inflammatory arm: Signs of uveitis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "All patients with uveitis seen in the uveitis clinic at the UW Medicine Eye Institute\n        would be eligible for participation in the uveitis arm of the study (n \u2264 50). Patients\n        with other, non-inflammatory forms of eye disease will be eligible for the\n        non-inflammatory arm of the study (n \u2264 50)."
            }
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01897935", 
            "org_study_id": "OFAM_PRO_120417"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Uveitis", 
        "lastchanged_date": "April 30, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seattle", 
                    "country": "United States", 
                    "state": "Washington", 
                    "zip": "98195"
                }, 
                "name": "UW Medicine Eye Institute"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "overall_official": [
            {
                "affiliation": "UW Medicine Eye Institute", 
                "last_name": "Deborah Lam, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "UW Medicine Eye Institute", 
                "last_name": "Russell Van Gelder, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "United States: Institutional Review Board"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "OFAM algorithms for quantitation of ocular flare will be established by comparing the output of the OFAM device to the flare measurements obtained during the standard slit lamp examination.", 
            "measure": "Establish OFAM algorithms for quantitation of ocular flare", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01897935"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "OFAM data for various sub-groups (age and sex) will be compared in order to evaluate the degree to which each sub-group acts as a confounder for OFAM measurements.", 
            "measure": "Determine the impact that various potential confounders such as age and sex have on OFAM Measurements", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "source": "ChromoLogic, LLC", 
        "sponsors": {
            "collaborator": {
                "agency": "UW Medicine Eye Institute", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "ChromoLogic, LLC", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Observational Model: Case Control, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}